Steroid hormone receptor phosphorylation: Is there a physiological role? by Kuiper, G.G.J.M. (George) & Brinkmann, A.O. (Albert)
Molecular and Cellular Endocrinology, 100 (1994) 103-107 
0 1994 Elsevier Science Ireland Ltd. 0303.7207/94/$07.00 
103 
MCE 3209 
Steroid hormone receptor phosphorylation: is there a physiological role? 
G.G.J.M. Kuiper * and A.O. Brinkmann 
Department of Endocrinology and Reproduction, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, PO Box 1738, 
3000 DR Rotterdam, Netherlands 
(Received 26 November 1993) 
Key words: Hormone receptor; Steroid hormone; Transcription regulation; Protein phosphorylation; Protein kinase 
Summary 
All members of the steroid hormone receptor family are phosphoproteins. Additional phosphorylation occurs in 
the presence of hormone. This hormone-induced phosphorylation, which is 2- to 7-fold more than the basal 
phosphorylation, is a rapid process. All steroid receptors are phosphorylated at more than one single site. Most 
phosphorylation sites are located in the N-terminal domain, and phosphorylation occurs mainly on serine residues. 
Phosphorylation on threonine residues occurs in only a few cases. Phosphorylation on tyrosine residues has been 
found only for the estrogen receptor. Six different protein kinases are possibly involved in steroid receptor 
phosphorylation (estrogen receptor kinase; protein kinase A, protein kinase C; casein kinase II; DNA-dependent 
kinase; Ser-Pro kinases). Steroid receptor phosphorylation has been directly implicated in: activation of hormone 
binding, nuclear import of steroid receptors, modulation of binding to hormone response elements, and conse- 
quently in transcription activation. 
Introduction 
All members of the steroid hormone receptor family 
are phosphoproteins. These include the receptors for 
glucocorticoids, mineralocorticoids, progestins, estro- 
gens, androgens and 1,25_dihydroxyvitamin D,. In re- 
cent years, several detailed reviews on steroid receptor 
phosphorylation have appeared (Orti et al., 1992; 
Moudgil, 1990; Takimoto and Horwitz, 1993), and there 
are also several general reviews on phosphorylation of 
transcription factors (Meek, 1992; Hunter, 1992). The 
present short review focuses on recent developments 
and possible physiological roles of steroid receptor 
phosphorylation. 
Basal and hormone-dependent phosphorylation 
When target cells in culture or tissue slices are 
incubated for short or longer periods with 32P-ortho- 
phosphate, steroid receptors can be shown to be phos- 
phorylated after immunopurification and SDS-poly- 
acrylamide electrophoresis (SDS-PAGE) (Orti et al., 
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1992, and references therein). This phosphorylation 
occurs in the absence of ligand. Another proof for 
hormone independent phosphorylation of steroid re- 
ceptors is the fact that at least progesterone (PR), 
1,25_dihydroxyvitamin D, (VDR) and androgen (AR) 
receptors migrate on SDS-PAGE as multiple forms, 
and the number of these receptor forms can be manip- 
ulated by phosphatase treatment in cell-free systems 
(Sheridan et al., 1989; Jurutka et al., 1993a; Kuiper et 
al., 1991). On incubation of cells or tissues in culture 
with the respective ligands, steroid receptors become 
hyperphosphorylated. This extra phosphorylation is a 
rapid process ( < 30 min) and is associated with recep- 
tor transformation (Orti et al., 1992; Sheridan et al., 
1989; Van Laar et al., 1991). This is often used as an 
argument to stress the importance of steroid receptor 
phosphorylation. The stimulation reported ranged from 
2- to 7-fold (Kuiper et al., 1993; Sheridan et al., 1988; 
Beck et al., 1992; Mendel et al., 1987; Denton et al., 
1992; Washburn et al., 1991; Brown and DeLuca, 1990). 
Differences reported for one type of receptor in com- 
parable systems, might be due to variations in experi- 
mental conditions. A question which is not always 
addressed is whether labelling in vivo with 32P-ortho- 
phosphate has reached a steady state, an important 
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requirement for comparison of phosphorylation levels. 
Results obtained with short labelling times (< 2 h) can 
be useful, but tend to give prominence to rapidly 
turning over sites. On the other hand, most hormone 
sensitive phosphoproteins can be expected to equili- 
brate quickly with the 32Pi in the ATP pool, because 
their phosphorylation site(s) are constantly subject to 
the actions of kinases and phosphatases. Thus, they 
will contain small amounts of 32P in the unliganded 
state, and the phosphorylation level increases rapidly 
during stimulation (Garrison, 1993). Nevertheless, it 
usually takes 4-6 h before cells in culture have equili- 
brated the ATP-pool with the radioactive orthophos- 
phate. Whether the increase in steroid receptor phos- 
phorylation upon hormone treatment is the conse- 
quence of a conformational change, making the recep- 
tor a better substrate for a kinase(s) or a less good 
substrate for a phosphatase(s), is an open question. 
Direct effects of steroid hormones on the activity of 
kinases and/or phosphatases have not been described, 
but cannot be excluded. 
Localization of phosphorylation sites 
With regard to the localization of steroid receptor 
phosphorylation sites, it is now clear that progesterone, 
glucocorticoid, and androgen receptors are mainly 
phosphorylated in the amino-terminal domain (Hoeck 
and Groner, 1990; Sheridan et al., 1988; Denner et al., 
1990; Sullivan et al., 1988; Kuiper et al., 1993,). For the 
chicken PR a phosphorylation site in the hinge region 
between the DNA and ligand binding domain has also 
been reported (Denner et al., 1990). The 1,25 dihy- 
droxyvitamin D, receptor (VDR) is phosphorylated in 
a central fragment spanning the hinge region and a 
large part of the ligand binding domain, but also phos- 
phorylation of a site in the DNA-binding domain has 
been reported (Brown and DeLuca, 1991; Hsieh et al., 
1991). Multiple phosphorylation sites in the N-terminal 
domain have been found in the estrogen receptor. All 
these sites were serine residues (Ali et al., 1993). For 
the mineralocorticoid receptor, data on the sites of 
phosphorylation are not yet available, although it is 
known that hyperphosphorylation of this receptor by 
ligand binding can be induced (Alnemri et al., 1991). 
Identification of phosphorylation sites 
Phospho amino acid analysis has revealed that the 
glucocorticoid, progesterone, vitamin D,, and andro- 
gen receptors are phosphorylated on serine residues 
(Dalman et al., 1988; Sheridan et al., 1988; Brown and 
DeLuca, 1991; Kuiper, unpublished observations). In 
some cases minor phosphorylation on threonine 
residues has also been reported (Hoeck and Groner, 
1990; Bodwell et al., 1991). It should be realized that 
phospho-esters are unstable under the conditions of 
acid hydrolysis of proteins, and that consequently de- 
phosphorylation of the phospho amino acids and re- 
lease of free [32Pil occurs. Phospho-tyrosine is espe- 
cially unstable, and false negative results can therefore 
be obtained (Duclos et al., 1991). 
Results on phospho-amino acid analysis of estrogen 
receptors are confusing. Auricchio and co-workers have 
shown that calf, rat and human estrogen receptors are 
phosphorylated on tyrosine residues (Auricchio, 1989; 
Migliaccio et al., 1986). In contrast, other investigators 
have reported that mouse and calf uterus estrogen 
receptors are phosphorylated exclusively on serine 
residues (Washburn et al., 1991; Denton et al., 1992). 
The reason for these discrepancies is at present un- 
known. 
Identification of phosphorylated residues in steroid 
receptors has been shown to be a major task. Large 
amounts of purified receptors are needed, which, are 
difficult to obtain, because of the very low expression 
level of receptor proteins in target cells. After tryptic 
phospho-peptide mapping and microsequencing, seven 
phosphorylated residues in the mouse glucocorticoid 
receptor were identified (Bodwell et al., 1991). All sites 
but one were localized in the amino-terminal transacti- 
vation domain. Data on the influence of glucocorti- 
coids on the phosphorylation state of these sites are 
not yet available. 
Four phosphorylated sites in the chicken proges- 
terone receptor have been identified (Denner et al., 
1990; Poletti and Weigel, 1993). There are four Ser-Pro 
motifs in the chicken progesterone receptor, which are 
all phosphorylated. Two sites are substantially phos- 
phorylated in the absence of hormone, with a small 
increase in the presence of hormone, while phosphory- 
lation of two other sites are hormone-inducible. The 
hormone-inducible phosphorylation sites (Ser-367 and 
Ser-530) are flanking the DNA-binding domain. This 
could explain the differential sensitivity towards hor- 
mone, since it is generally believed that the DNA-bind- 
ing domain is exposed upon hormone binding, making 
sites available for phosphorylation. 
Upon expression of chicken progesterone receptor 
in the yeast Saccharomyces cerevisiae, it was also shown 
that in this system the receptor is correctly phosphory- 
lated on all four Ser-Pro motives (Poletti et al., 1993). 
The effects of hormone on the degree of phosphoryla- 
tion of the four sites were consistent with those ob- 
tained in the authentic chicken PR, showing that the 
yeast system is appropriate for the study of the role of 
phosphorylation in PR function. 
Protein kinases and steroid receptor phosphorylation 
Progesterone receptors can be phosphorylated in 
vitro by several kinases. Protein kinase A phosphory- 
lates purified A and B forms of the chicken oviduct 
progesterone receptor on serine residues (Nakao et al., 
1992). Multiple phosphopeptides were resolved by 
two-dimensional tryptic peptide mapping. However, no 
direct comparison was made with in vivo phosphory- 
lated receptor. Chicken progesterone receptor is also 
phosphorylated by a DNA-dependent protein kinase 
during in vitro PR-dependent transcription assays us- 
ing HeLa cell nuclear extracts. This phosphorylation is 
strictly dependent on the presence of double-stranded 
DNA. (Weigel et al., 1992). These experiments uggest 
that, apart from the hormone-independent and hor- 
mone-dependent phosphorylations, an additional series 
of ph.osphorylations may be required for activation of 
the progesterone receptor. Further analysis of recep- 
tors isolated from chicken oviduct nuclear extracts will 
be necessary to determine if this phosphorylation also 
occurs in vivo. The DNA-dependent kinase that is 
involved also phosphorylates the transcription factor 
Spl, and is a heterodimer composed of a catalytic 
subunit and a DNA binding subunit. The latter directs 
the kinase to DNA and can be regarded as a “target- 
ting subunit”, making efficient phosphorylation of 
DNA-bound substrates possible (Hubbard and Cohen, 
1993). 
Cell-free phosphorylation of calf uterine estrogen 
receptors has been found to occur on tyrosine residues 
(Auricchio, 1989). A nuclear phosphatase from calf 
uterus inactivated hormone binding, and this dephos- 
phorylated receptor form could be converted to an 
estradiol binding form again by a cytosolic calcium 
calmodulin-dependent tyrosine kinase (Auricchio, 1989, 
and references therein). This kinase has now been 
purified to homogeneity (Castoria et al., 1993). The 
uterus tyrosine kinase is a 67 kDa protein on SDS- 
PAGE and binds calmodulin in a Cazf dependent 
manner. In vitro the kinase phosphorylates the estra- 
diol receptor on tyrosine, and thereby activates recep- 
tor hormone binding. By site-directed mutagenesis of 
tyrosine residues in the in vitro translated human es- 
trogen receptor, tyrosine 537 was identified as the 
phosphorylated residue. This mutant (Tyr + Phe) is 
neither phosphorylated nor activated with regard to 
ligand binding by the kinase. Remarkably, the kinase is 
dependent for its activity on the presence of purified 
calf uterus estradiol receptor. It is an open question 
whether the kinase is activated by estradiol, the estra- 
diol receptor complex or by an unknown compound in 
the purified receptor preparation. Furthermore, it has 
not yet been shown that the estradiol receptor in calf 
uterus in vivo is also phosphorylated on tyrosine residue 
537, and that this phosphorylation is essential for hor- 
mone-binding activation. 
The vitamin D receptor is phosphorylated in vitro by 
casein kinase II, protein kinase A (PKA) and protein 
kinase C (PKC) (Hsieh et al., 1991; Jurutka et al., 
1993b; Jones et al., 1991). In a detailed series of 
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experiments, it was shown that the VDR is phosphory- 
lated in vitro as well as in vivo on serine residue 51 by 
PKC (Hsieh et al., 1991; Hsieh et al., 1993). Phospho- 
peptide mapping along with identification of the PKA 
and casein kinase II phosphorylation sites, utilizing site 
specific mutagenesis, will be required to unequivocally 
demonstrate the involvement of PKA and casein kinase 
II in the phosphorylation of VDR in vivo. 
It can be concluded that six different kinases 
(estrogen receptor kinase, PKA, PKC, Casein Kinase 
II, DNA-dependent kinase., Ser-Pro directed kinases) 
have so far been reported to phosphorylate steroid 
receptors, and that all receptors are phosphorylated at 
more than one single site. Furthermore, most of the 
sites reported have been shown to be only partly phos- 
phorylated. It follows that within a cell several popula- 
tions of receptors exists, each with different numbers 
or patterns of phosphorylated sites and possibly each 
with different biological activities. 
Receptor phosphorylation and receptor function 
There is increasing evidence that gene expression is 
regulated by phosphorylation of transcription factors 
(Hunter and Karin, 1992). Since steroid receptors are 
known as ligand-inducible transcription factors and 
also exist as phosphoproteins, several studies have been 
performed to uncover a physiological role for receptor 
phosphorylation in steroid hormone action. The follow- 
ing receptor functions or activities linked to phosphory- 
lation have been suggested: receptor association with 
heat-shock proteins, activation of hormone-binding, 
nuclear import, subnuclear localization, nucleo-cyto- 
plasmic shuttling, modulation of binding to hormone 
response elements, receptor-dimerization, interactions 
with other transcription factors, and receptor half-life 
(e.g. receptor turnover and recycling). Despite the fact 
that a number of phosphorylation sites in several steroid 
receptors are known, mutagenesis studies have not 
revealed the expected clear picture of effects on biolog- 
ical activity. 
The estrogen receptor is the only steroid receptor 
which is phosphorylated on a tyrosine residue in the 
hormone-binding domain (Auricchio, 1989). Extensive 
in vitro studies have demonstrated that this phosphory- 
lation is dependent on the estradiol-receptor complex 
and is activated by a Ca2+ calmodulin-dependent ki- 
nase. Phosphorylation in vitro of the dephosphorylated 
estrogen receptor is essential for activation of hor- 
mone-binding (Castoria et al., 1993). 
In sharp contrast to these studies, there are several 
observations on estrogen receptor phosphorylation only 
on serine residues. Denton et al. (1992) have reported 
that the ER from the MCF-7 breast carcinoma cell 
line, as well as the ER from calf uterine slices, was 
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phosphorylated in the presence of hormone only on 
serine residues, and that treatment with phosphatase 
caused loss of affinity of the ER for specific DNA 
sequences. Activation of transcription by the rat estro- 
gen receptor can be stimulated &to lo-fold by S-Br- 
CAMP, cholera toxin and insulin-like growth factor I. 
These agents also elicit a 3- to 5-fold increase in 
overall phosphorylation of the receptor (Aronica and 
Katzenellenbogen, 1993). However, the fact that an 
anti-estrogen evokes a similar increase in ER phospho- 
rylation, without a similar increase in ER activation of 
transcription, indicates that an increase in overall 
phosphorylation does not necessarily result in in- 
creased transcriptional activity. Transactivation of the 
ER, therefore, might depend upon phosphorylation of 
a specific site or sites, the modulation of which might 
not be detected in overall phosphorylation. In another 
study involving transfection of COS cells with ER, 
multiple phosphorylation sites in the N-terminal do- 
main were found, all on serine residues (Ali et al., 
1993). Mutation of one serine residue (position 118 in 
the human estrogen receptor) caused a significant re- 
duction in transcription activation by the receptor, but 
did not affect the DNA-binding properties or nuclear 
import of the receptor. The serine residue at position 
118 co-localizes with the transcription activation func- 
tion 1 (W-1) in the N-terminal domain (Ali et al., 
1993). 
Kinetic data on in vitro transcription by the hPR has 
reve,aled a positive correlation between progesterone- 
dependent phosphorylation of the PR and the proges- 
terone induced enhancement of RNA synthesis from a 
PRE-driven promoter (Bagchi et al., 1992). Although 
in the chicken progesterone receptor four different 
phosphorylation sites have b,een identified, no data on 
functional significance are available yet. Hyperphos- 
phorylation of the progesterone receptor is not corre- 
lated with increased transcriptional activity, because 
the antagonist RU486 provokes hyperphosphorylation 
in the rabbit progesterone receptor, whereas a consti- 
tutively active progesterone receptor mutant is not 
hyperphosphorylated (Chaucherau et al., 1991). Care- 
ful comparison by two-dimensional tryptic phospho- 
peptide mapping could resolve the differences in phos- 
phorylation of the PR after treatment with RU486 or 
progesterone. 
In, the mouse glucocorticoid receptor, seven .phos- 
phorylation sites have been identified (Bodwell et al., 
.1991>.. S.ingle mutations at all seven sites, or combina- 
tions of substitutions, elicited levels of hormone-in- 
duced reporter gene expression that are comparable to 
wild type receptors (Mason and Housley, 1993). From 
these studies, it can be concluded that phosphorylation 
of ,the GR at the seven identified sites is not a major 
determinant in GR mediated transcription activation. 
Other studies with the GR indicate that receptor phos- 
phorylation could affect .intracellular trafficking. Nu- 
clear retention is inhibited by several phosphatase in- 
hibitors, but not nuclear uptake. Dephosphorylation of 
the GR might promote cytoplasmic trapping of the 
GR. Hormone-dependent phosphorylation of the GR 
may in fact serve as a mechanism for regulating the 
intracellular distribution, via changes in nucleo-cyto- 
plasmic shuttling (Hsu et al., 1992; Orti et al., 1993) 
Phosphorylation of various components of the GR 
signal transduction pathway, and not necessarily the 
receptor itself, may influence its transcriptional en- 
hancement activity (DeFranco et al., 1991; Moyer et 
al., 1993). 
The human vitamin D receptor is selectively phos- 
phorylated by protein kinase C on serine at position 51. 
This serine residue lies in a position between the two 
zinc fingers that constitute the DNA binding domain. 
Mutation of the serine residue at position 51 to a 
negatively charged aspartic acid residue markedly re- 
duced the binding of the VDR to a vitamin D respon- 
sive element and consequently the transcriptional activ- 
ity (Hsieh et al., 1993). Alteration of serine 51 to 
alanine in the hVDR eliminated phosphorylation but 
preserved completely the specific DNA binding activity 
and transactivation capacity. It has been suggested that 
phosphorylation at serine 51 could silence the hVDR 
via a negative regulation of DNA binding when target 
cells are subject to PK-C activation events (Hsieh et al., 
1993). 
Conclusions 
For all steroid receptors, overwhelming evidence is 
reported for hyperphosphorylation of the receptor af- 
ter ligand binding. In some cases, this can result in 
increased transcriptional activity. Phosphorylation can 
increase the negative charge and acidity of a region of 
a protein, thereby modifying interactions with other 
proteins or with DNA. Hypo- and hyperphosphoryla- 
tion at the same time in different regions of steroid 
receptor molecules might provide a mechanism for 
differential transcription regulation of certain genes, in 
addition to host cell and promoter context of the genes 
to be transcribed or repressed. The possible role of 
altered phosphorylation states of steroid receptors may 
be illustrated by studies with SV 40 large T antigen and 
c-fos in which differential phosphorylation produced 
different cellular actions (Prives, 1990; Ofir et al., 
1990). The fact that there are so many phosphorylation 
sites affected by different kinases/ phosphatases and 
signal transduction pathways, might indicate that phos- 
phorylation is involved in the regulation of multiple 
receptor functions. In this respect, a further identifica- 
tion of kinases and phosphatases involved in steroid 
receptor phosphorylation,’ dephosphorylation, as well 
as their regulation, are necessary for a better under- 
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standing of the role of receptor phosphorylation in 
steroid hormone action. Additional mutagenesis tud- 
ies of phosphorylation sites in vitro and in vivo (ho- 
mologous recombination experiments), and structural 
analysis studies at the three-dimensional level (X-ray 
analysis and NMR studies), might help further to eluci- 
date and understand the consequences of the introduc- 
tion of a negative phosphate group for the structure 
and activity of these ligand-induced transcription fac- 
tors. 
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